In March 2025, the company introduced new strategies to get a immediate-to-buyer supplying of its Wegovy weight loss drug. The company proven a different pharmacy, termed NovoCare, which might cost clients $499 every month for use of the drug, below 50 percent the price of the drug through other pharmaceutical distribution networks.[fifty three]At